openPR Logo
Press release

Huntingtin (Huntington Disease Protein or HTT) Therapeutic Landscape and Pipeline Review, H2, 2017

11-02-2017 11:10 AM CET | Health & Medicine

Press release from: Market Research Hub

Market_Research_Hub

Market_Research_Hub

Market Research Hub (MRH) has included a new research report titled “Huntingtin (Huntington Disease Protein or HTT) Pipeline Review H2 2017”, outlays complete info on the Huntingtin or Huntington Disease Protein or HTT targeted therapeutics, whole with the strong analysis by indications, route of administration (RoA), mechanism of action (MoA), stage of development and molecule type; that are being established by Companies / Universities.

Request Free Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1361348

According to the recently published report Huntingtin-Pipeline Review, H2 2017; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes.

Huntingtin (Huntington Disease Protein or HTT)-Huntingtin protein is an encoded by the huntingtin gene, also called the HTT or HD (Huntington disease) gene. Huntingtin up regulates the expression of brain derived neurotrophic factor (BDNF) at the transcription level. Huntingtin is primarily associated with vesicles and microtubules. These indicate an important role in cytoskeletal anchoring or transport of mitochondria. The Htt protein is involved in vesicle trafficking as it interacts with HIP1 to mediate endocytosis. Huntingtin also plays an important role in the establishment in epithelial polarity through its interaction with RAB11A.

It also reviews key players involved in Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, the molecules developed by companies in Phase II, Preclinical and Discovery stages are 3, 7 and 4 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively. Report covers products from therapy areas Central Nervous System and Genetic Disorders which include indications Huntington Disease, Alzheimers Disease, Kennedys Disease (Spinal and Bulbar Muscular Atrophy) and Spinocerebellar Ataxia (SCA).

Scope:
- The report provides a snapshot of the global therapeutic landscape for Huntingtin (Huntington Disease Protein or HTT)
- The report reviews Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics and enlists all their major and minor projects
- The report assesses Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Huntingtin (Huntington Disease Protein or HTT) targeted therapeutics

Reasons to buy:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Huntingtin (Huntington Disease Protein or HTT)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Huntingtin (Huntington Disease Protein or HTT) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Browse Full Report with TOC @ https://www.marketresearchhub.com/report/huntingtin-huntington-disease-protein-or-htt-pipeline-review-h2-2017-report.html

Table of Content:
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Huntingtin (Huntington Disease Protein or HTT)-Overview
Huntingtin (Huntington Disease Protein or HTT)-Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Huntingtin (Huntington Disease Protein or HTT)-Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Huntingtin (Huntington Disease Protein or HTT)-Companies Involved in Therapeutics Development
AFFiRiS AG
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
nLife Therapeutics SL
PTC Therapeutics Inc
reMYND NV
Shire Plc

….continue

Enquire about this report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1361348

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: https://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Huntingtin (Huntington Disease Protein or HTT) Therapeutic Landscape and Pipeline Review, H2, 2017 here

News-ID: 798298 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Huntingtin

Huntington's Disease Market Future Scope, Opportunities with Strategic Growth an …
New York, Global Huntington's Disease Market report from Global Insight Services is the single authoritative source of intelligence on Huntington's Disease Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,
Huntington's Disease - Drug Pipeline Landscape, 2022
Huntington's disease is a progressive brain disorder caused by a single defective gene on chromosome 4. This gene produces a protein called huntingtin, which is essential for normal brain development. However, when the gene is defective, it produces an abnormal form of huntingtin that is toxic to brain cells. The damage caused by the abnormal protein gradually destroys certain nerve cells in the brain, which leads to the characteristic symptoms
Huntington's Disease Market Insights by 2031 & Covid-19 Analysis | Key players N …
New York, Global Huntington's Disease Market report from Global Insight Services is the single authoritative source of intelligence on Huntington's Disease Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,
Huntington’s Disease Treatment Market Worldwide Top Players Revenue and Foreca …
Huntington's disease, also known as Huntington's chorea, is an autosomal dominant inherited rare disorder that causes progressive degeneration of nerve cell of brain leading to deterioration of a person’s physical and mental abilities. Huntington's disease symptoms usually are detected at the age of 30–50 and gets worse over 10 to 25 year period from the onset of disease. Huntington's disease is usually associated with movement disorders, cognitive disorders or psychiatric
Huntington’s Disease Treatment Market-By Drug Type, Distribution Channel
Huntington's disease, also known as Huntington's chorea, is an autosomal dominant inherited rare disorder that causes progressive degeneration of nerve cell of brain leading to deterioration of a person’s physical and mental abilities. Huntington's disease symptoms usually are detected at the age of 30–50 and gets worse over 10 to 25 year period from the onset of disease. Huntington's disease is usually associated with movement disorders, cognitive disorders or psychiatric
Huntingtin (Huntington Disease Protein or HTT)-Pipeline Review, H2 2017
"The Report Huntingtin (Huntington Disease Protein or HTT)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" According to the recently published report Huntingtin-Pipeline Review, H2 2017; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. Huntingtin (Huntington Disease Protein or HTT)-Huntingtin